Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04270175 |
|---|---|
| Brief Title: | Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab |
| First Submitted : | February 12, 2020 |
| First Submitted that Met QC Criteria : | February 12, 2020 |
| First Posted : | February 17, 2020 |
| Last Update Submitted that Met QC Criteria : | June 8, 2022 |
| Last Update Posted : | June 9, 2022 |